본문 바로가기

NSAID-induced gastropathy and H. pylori infection

문서 유형
연구출판물 · 저서
등재
Scopus
저널
Helicobacter pyloripp.395 · 2024
피인용
Scopus 0
FWCI (Scopus)
0

저자

  1. 김광하제1저자교신저자Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea

초록

Gastrointestinal (GI) injury caused by nonsteroidal anti-infammatory drugs (NSAIDs) or Helicobacter pylori (H. pylori) occurs via different mechanisms. If these two factors coexist, the risk of GI injury increases independently and sometimes synergistically. In high-risk patients who require NSAID administration, examination of H. pylori infection is recommended followed by eradication therapy to prevent peptic ulcer in patients with confrmed H. pylori infection. A similar strategy is recommended for initial NSAID (excluding aspirin) users and long-term aspirin users with a history of peptic ulcer complications. In countries where the incidence of H. pylori infection is high, such as Korea, prevention and treatment strategies for NSAID users with H. pylori infection should differ from those in Western countries. Long-term multicenter studies that consider the current clinical situation are necessary in the future.

키워드

GastropathyHelicobacter pyloriNonsteroidal anti-infammatory drugsPeptic ulcer

식별자

Scopus EID
2-s2.0-85202006549